FIM
GILD icon

Fruth Investment Management’s Gilead Sciences GILD Stock Holding History

Fruth Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,525
Closed -$212K – 229
2026
Q1 		$212K Sell
1,525
-600
-28% -$84K 0.05% 206
2025
Q4 		$260K Buy
2,125
+7
+0.3% +$851 0.07% 190
2025
Q3 		$235K Hold
2,118
– – 0.06% 195
2025
Q2 		$234K Hold
2,118
– – 0.06% 190
2025
Q1 		$237K Buy
+2,118
New +$219K 0.07% 188

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fruth Investment Management's GILD Position: Q2 2026 in Review

Fruth Investment Management sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,525 shares — an estimated $212K sold.

Fruth Investment Management first reported a position in GILD in Q1 2025 and held it in 5 quarters. The position peaked at $260K in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Fruth Investment Management reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Fruth Investment Management sold 1,525 Gilead Sciences shares in Q2 2026, an estimated $212K.
  • Fruth Investment Management first reported a position in Gilead Sciences in Q1 2025 and held it in 5 quarters.
  • Fruth Investment Management's Gilead Sciences position peaked at $260K in Q4 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Fruth Investment Management's 13F filing for Q2 2026, filed 10 Jul 2026.